Ontario, Canada (CU)_ KYE Pharmaceuticals Inc. (“KYE”), a privately held company based in Mississauga, Ontario, delivers pharmaceuticals to the Canadian market to address clinically important unfulfilled medical needs. According to the company’s recent announcement, it has submitted a New Drug Submission (NDS) for Accrufer® (ferric maltol) to Health Canada for regulatory inspection and authorization of the medication.
A New Drug Submission for the treatment of iron deficiency by KYE Pharmaceuticals!
- Advertisement -
Popular Categories
Previous article![]( "Jazz Pharmaceuticals to open a new production facility for cannabis-based medications")
Next article![]( "A personal tribute from the Queen to her husband")
